- Home
- Publications
- Publication Search
- Publication Details
Title
Glycoconjugate vaccines: an update
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 15, Issue 4, Pages 529-546
Publisher
Informa Healthcare
Online
2014-12-11
DOI
10.1517/14712598.2015.993375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improving access to vaccines through tiered pricing
- (2014) Seth Berkley LANCET
- Timing of an Adolescent Booster after Single Primary Meningococcal Serogroup C Conjugate Immunization at Young Age; An Intervention Study among Dutch Teenagers
- (2014) Susanne P. Stoof et al. PLoS One
- Benefits of using vaccines out of the cold chain: Delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin
- (2014) Simona Zipursky et al. VACCINE
- Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?
- (2014) Catherine Weil-Olivier et al. VACCINE
- Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: A phase II randomized clinical trial
- (2014) Roman Prymula et al. VACCINE
- Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial
- (2014) Miguel W. Tregnaghi et al. PLOS MEDICINE
- Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies
- (2014) Laura L Hammitt et al. Lancet Global Health
- Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination
- (2013) P. C. S. de Whalley et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine
- (2013) Paul A Kristiansen et al. BMC INFECTIOUS DISEASES
- Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children
- (2013) Mark van der Linden et al. BMC INFECTIOUS DISEASES
- Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study
- (2013) Charissa Borja-Tabora et al. BMC INFECTIOUS DISEASES
- Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination
- (2013) Jean-Marc Collard et al. BMC INFECTIOUS DISEASES
- Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012
- (2013) Walter H.B. Demczuk et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Identification of Haemophilus influenzae Clones Associated with Invasive Disease a Decade after Introduction of H. influenzae Serotype b Vaccination in Italy
- (2013) Maria Giufrè et al. Clinical and Vaccine Immunology
- Invasive Haemophilus influenzae Type b Disease in England and Wales: Who Is at Risk After 2 Decades of Routine Childhood Vaccination?
- (2013) S. Collins et al. CLINICAL INFECTIOUS DISEASES
- Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction
- (2013) S. GEORGES et al. EPIDEMIOLOGY AND INFECTION
- Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2–10-year-old children: results of an open, randomised, controlled study
- (2013) Markus Knuf et al. EUROPEAN JOURNAL OF PEDIATRICS
- Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 – 17 years
- (2013) Ruth Mitchell et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Advances towards the prevention of meningococcal B disease: A multidimensional story
- (2013) Marion Roderick et al. JOURNAL OF INFECTION
- Incidence of Haemophilus influenzae Type b Disease in The Gambia 14 Years after Introduction of Routine Haemophilus influenzae Type b Conjugate Vaccine Immunization
- (2013) Claire Oluwalana et al. JOURNAL OF PEDIATRICS
- Impact and Cost-Effectiveness of Haemophilus influenzae Type b Conjugate Vaccination in India
- (2013) Andrew D. Clark et al. JOURNAL OF PEDIATRICS
- Cost-Effectiveness of Haemophilus influenzae Type b Conjugate Vaccine in Low- and Middle-Income Countries: Regional Analysis and Assessment of Major Determinants
- (2013) Ulla Kou Griffiths et al. JOURNAL OF PEDIATRICS
- 13-valent Pneumococcal Conjugate Vaccine in Older Children and Adolescents Either Previously Immunized With or Naïve to 7-valent Pneumococcal Conjugate Vaccine
- (2013) Robert Frenck et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Comparative Immunogenicity of 7 and 13-Valent Pneumococcal Conjugate Vaccines and the Development of Functional Antibodies to Cross-Reactive Serotypes
- (2013) Lindsay R. Grant et al. PLoS One
- Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X
- (2013) F. Micoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety of 13-valent pneumococcal conjugate vaccine in infants and children: Meta-analysis of 13 clinical trials in 9 countries
- (2013) Allison Thompson et al. VACCINE
- Effectiveness of meningococcal serogroup C vaccine programmes
- (2013) Ray Borrow et al. VACCINE
- CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens
- (2013) Sharad K. Sharma et al. VACCINE
- Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
- (2013) Lisa A. Jackson et al. VACCINE
- Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
- (2012) Stephanie R Earnshaw et al. BMC INFECTIOUS DISEASES
- Risk of Invasive Haemophilus influenzae Type b (Hib) Disease in Adults with Secondary Immunodeficiency in the Post-Hib Vaccine Era
- (2012) Eli B. Nix et al. Clinical and Vaccine Immunology
- Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity
- (2012) Paul A. Kristiansen, Fabien Diomandé, Absatou Ky Ba, Idrissa Sanou, Abdoul–Salam Ouédraogo, Rasmata Ouédraogo, Lassana Sangaré, Denis Kandolo, Flavien Aké, Inger Marie Saga, Thomas A. Clark, Lara Misegades, Stacey W. Martin, Jennifer Dolan Thomas, Sylvestre R. Tiendrebeogo, Musa Hassan-King, Mamoudou H. Djingarey, Nancy E. Messonnier, Marie-Pierre Préziosi, F. Marc LaForce, Dominique A. Caugant CLINICAL INFECTIOUS DISEASES
- Two Decades of Experience With the Haemophilus influenzae Serotype b Conjugate Vaccine in the United Kingdom
- (2012) Shamez N. Ladhani CLINICAL THERAPEUTICS
- Glycoconjugate vaccines
- (2012) David Pace EXPERT OPINION ON BIOLOGICAL THERAPY
- Persistence of antibodies for 42 months following vaccination of adolescents with a meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine (MenACWY-TT)
- (2012) Lars Østergaard et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England
- (2012) Albert Jan van Hoek et al. JOURNAL OF INFECTION
- Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
- (2012) Arto A Palmu et al. LANCET
- Immunogenicity of a Single Dose of Meningococcal Group C Conjugate Vaccine Given at 3 Months of Age to Healthy Infants in the United Kingdom
- (2012) Helen Findlow et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Evaluation of Haemophilus influenzae Type b Vaccine for Routine Immunization in Nepali Infants
- (2012) Jane Astrid Metz et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period
- (2012) Gaston De Serres et al. VACCINE
- Meningococcal serogroup Y emergence in Europe
- (2012) Michael Bröker et al. Human Vaccines & Immunotherapeutics
- The changing epidemiology of meningococcal disease in North America 1945–2010
- (2012) Carmen Baccarini et al. Human Vaccines & Immunotherapeutics
- Haemophilus influenzaetype b conjugate vaccines: Considerations for vaccination schedules and implications for developing countries
- (2011) Sean P. Fitzwater et al. Human vaccines & immunotherapeutics
- 13-valent pneumococcal conjugate vaccine (PCV13)
- (2011) Johanna MC Jefferies et al. Human vaccines & immunotherapeutics
- Meningococcal glycoconjugate vaccines
- (2011) Roberto Gasparini et al. Human vaccines & immunotherapeutics
- Haemophilus influenzae Infections in the H. influenzae Type b Conjugate Vaccine Era
- (2011) Aarti Agrawal et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
- (2011) Samba O. Sow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity and Safety of H influenzae Type b-N meningitidis C/Y Conjugate Vaccine in Infants
- (2011) K. A. Bryant et al. PEDIATRICS
- Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso
- (2011) Isabelle Delrieu et al. PLoS One
- Healthcare utilization and cost of pneumococcal disease in the United States
- (2011) Susan S. Huang et al. VACCINE
- An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children
- (2011) Markus Knuf et al. VACCINE
- Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model
- (2011) Julie M. Skinner et al. VACCINE
- Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?
- (2010) William P Hausdorff et al. BMC Pediatrics
- Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers
- (2010) S. Esposito et al. Clinical and Vaccine Immunology
- Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity
- (2010) H. Campbell et al. Clinical and Vaccine Immunology
- Antibody Persistence after Serogroup C Meningococcal Conjugate Immunization of United Kingdom Primary‐School Children in 1999–2000 and Response to a Booster: A Phase 4 Clinical Trial
- (2010) K. P. Perrett et al. CLINICAL INFECTIOUS DISEASES
- Global prevailing and emerging pediatric pneumococcal serotypes
- (2010) E David G McIntosh et al. Expert Review of Vaccines
- Continued control of pneumococcal disease in the UK - the impact of vaccination
- (2010) R. A. Gladstone et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine
- (2010) K. A. Bryant et al. PEDIATRICS
- Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers
- (2010) S. H. Yeh et al. PEDIATRICS
- Global use of Haemophilus influenzae type b conjugate vaccine
- (2010) Linda R. Ojo et al. VACCINE
- Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: Evidence for herd effects and strain replacement due to Hib vaccination
- (2010) H.J. Adam et al. VACCINE
- Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany
- (2010) Dorothee M. Kieninger et al. VACCINE
- Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project
- (2010) Hope L. Johnson et al. PLOS MEDICINE
- Caseinolytic protease: a protein vaccine which could elicit serotype-independent protection against invasive pneumococcal infection
- (2009) J. Cao et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Long‐Term Immunological Follow‐Up of Children withHaemophilus influenzaeSerotype b Vaccine Failure in the United Kingdom
- (2009) Shamez Ladhani et al. CLINICAL INFECTIOUS DISEASES
- Invasive Pneumococcal Disease among Adults: Associations among Serotypes, Disease Characteristics, and Outcome
- (2009) Angelique G. S. C. Jansen et al. CLINICAL INFECTIOUS DISEASES
- Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease
- (2009) Amanda C. Cohn et al. CLINICAL INFECTIOUS DISEASES
- Pneumococcal conjugated vaccine: PHiD-CV
- (2009) Ener Cagri Dinleyici et al. Expert Review of Anti-Infective Therapy
- Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines
- (2009) Daniel J. Isaacman et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
- (2009) Tamara Pilishvili et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity of Haemophilus influenzae Type b Conjugate Vaccines in Korean Infants: A Meta-analysis
- (2009) Hyunju Lee et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates
- (2009) James P Watt et al. LANCET
- Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine
- (2009) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Randomized Trial to Assess Immunogenicity and Safety of Haemophilus influenzae Type b and Neisseria meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine in Infants
- (2009) Colin D. Marchant et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age
- (2009) Roman Prymula et al. VACCINE
- Global epidemiology of meningococcal disease
- (2009) Lee H. Harrison et al. VACCINE
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
- (2008) Martin C. J. Maiden et al. JOURNAL OF INFECTIOUS DISEASES
- The effect of vaccination on Streptococcus pneumoniae resistance
- (2008) Eugene Leibovitz Current Infectious Disease Reports
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now